UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

 (Check One)  [ ] Form 10-K and Form 10-KSB[ ] Form 20-F [ ] Form 11-K

              [X] Form 10-Q and Form 10-QSB[ ] Form N-SAR

For Period Ended: February 28, 2005

              [ ] Transition Report on Form 10-K

              [ ] Transition Report on Form 20-F

              [ ] Transition Report on Form 11-K

              [ ] Transition Report on Form 10-Q

              [ ] Transition Report on Form N-SAR

              For the Transition Period Ended: _______________________

Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has

verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:    N/A

PART 1

REGISTRANT INFORMATION

 

 

Full Name of Registrant:

US BIODEFENSE, INC.

 

Former Name if Applicable:

PIEDMONT, INC.

 

 

Address of Principal Executive Office
Street and Number:	13674 E. Valley Blvd.
City, State and Zip Code:	City of Industry, California 91746

PART II

RULES 12B-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to RULE 12b-25(b), the following should be completed.  (Check box if appropriate)

[X]      (a)      The reasons described in reasonable detail in Part III of

                  this form could not be eliminated without unreasonable

                  effort or expense;

[X]      (b)      The subject annual report, semi-annual report, transition

                  report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or

                  portion thereof, will be filed on or before the fifteenth

                  calendar day following the prescribed due date; or the

                  subject quarterly report or transition report on Form 10-Q,

                  or portion thereof will be filed on or before the fifth

                  calendar day following the prescribed due date; and

[ ]      (c)      The accountant's statement or other exhibit required by

                  RULE 12b-25(c) has been attached if applicable.

PART III

NARRATIVE

The Registrant's quarterly report on Form 10-QSB cannot be filed within the prescribed time period due to the accountants requiring additional time to prepare the financial statements of the Registrant.

PART IV

OTHER INFORMATION

(1)      Name and telephone number of person to contact in regard to this

         notification

David Chin		(626)		961-8039
(Name)		(Area Code)		(Telephone Number)

(2)      Have all other periodic reports required under Section 13 or 15(d)

         of the Securities Exchange Act of 1934 or Section 30 of the

         Investment Company Act of 1940 during the preceding 12 months (or

         for such shorter period that the registrant was required to file

         such reports) been filed?

         If the answer is no, identify report(s).  [X] Yes [ ] No

(3)      Is it anticipated that any significant change in results of

         operations from the corresponding period for the last fiscal year

         will be reflected by the earnings statements to be included in the

         subject report or portion thereof? [ ] Yes [X] No

         If so, attach an explanation of the anticipated change, both

         narratively and quantitatively, and, if appropriate, state the

         reasons why a reasonable estimate of the results cannot be made.

US Biodefense, Inc.

(Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date: April 18, 2005

                            

                            By: /s/ David Chin

                            Name:   David Chin

                            Title:  President